The Early Detection Research Network: Clinical Validation Centers (U01)

The summary for the The Early Detection Research Network: Clinical Validation Centers (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

The Early Detection Research Network: Clinical Validation Centers (U01): The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for Clinical Validation Centers (CVCs), one of the four scientific units of the Early Detection Research Network (EDRN). The EDRN is a national infrastructure funded to discover, develop, and validate biomarkers for risk assessment, detection, and molecular diagnosis and prognosis of early cancer. The proposed CVCs will be responsible for clinical research on the validation of biomarkers. CVCs will also serve as clinical resource centers for the EDRN by participating in collaborative biomarker validation studies and collaborating with the other scientific units of the EDRN.
The other three scientific components of the continuing EDRN program are: the Biomarker Developmental Laboratories (BDLs), which will be responsible for the development and characterization of new, or the refinement of existing, biomarkers and biomarker assays for risk assessment, detection, and molecular diagnosis and prognosis of early cancer; the Biomarker Reference Laboratories (BRLs), which will serve as Network resources for clinical and laboratory validation of biomarkers; and the Data Management and Coordinating Center (DMCC), which will support statistical and computational analyses, informatics infrastructure, study design, coordination and support of EDRN-sponsored biomarker validation studies, and the coordination of Network-wide meetings and conferences.

Federal Grant Title:	The Early Detection Research Network: Clinical Validation Centers (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-CA-14-015
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.394
CFDA Descriptions:	Cancer Detection and Diagnosis Research
Current Application Deadline:	Jan 6, 2015
Original Application Deadline:	Jan 6, 2015
Posted Date:	November 6th, 2014
Creation Date:	Nov 6, 2014
Archive Date:	Feb 6, 2015
Total Program Funding:	$9,000,000
Maximum Federal Grant Award:	$600,000
Minimum Federal Grant Award:	none
Expected Number of Awards:	8
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Private institutions of higher education
Native American tribal governments (Federally recognized)
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
County governments
Others (see text field entitled "Additional Information on Eligibility" for clarification)
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-14-015.html
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants: • Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologi...; • Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Ca...; • Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate C...; • Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic...; • Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Ca...; • Image-Guided Cancer Interventions (STTR [R41/R42]); • An SBIR Initiative for Image-Guided Cancer Interventions (R43/R44); • In Vivo Cancer Imaging Exploratory/Developmental Grants
More Grants from the National Institutes of Health: • The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...; • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional); • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...